Page last updated: 2024-11-05

trihexyphenidyl and Chronic Hepatitis C

trihexyphenidyl has been researched along with Chronic Hepatitis C in 1 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cocco, GA1
Loudianos, G1
Pes, GM1
Tolu, F1
Lepori, MB1
Barrocu, M1
Sechi, GP1

Other Studies

1 other study available for trihexyphenidyl and Chronic Hepatitis C

ArticleYear
"Acquired" hepatocerebral degeneration in a patient heterozygote carrier for a novel mutation in ATP7B gene.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Aug-15, Volume: 24, Issue:11

    Topics: Adenosine Triphosphatases; Adult; Amino Acid Substitution; Basal Ganglia; Cation Transport Proteins;

2009